Tritt ein in eine Welt voller Geschichten
Frontiers in Cardiovascular Drug Discovery is a book series devoted to publishing the latest advances in cardiovascular drug design and discovery. Each volume brings reviews on the biochemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships of molecules used in cardiovascular therapy. The book series should prove to be of great interest to all medicinal chemists and pharmaceutical scientists involved in preclinical and clinical research in cardiology.
The fifth volume of the series covers the following topics:
-The Lipid Hypothesis: From Resins to Proprotein Convertase Subtilisin/Kexin Type-9 Inhibitors -The Role of SGLT2i in the Prevention and Treatment of Heart Failure -Natural Products and Semi-Synthetic Compounds as Antithrombotics: A Review of the Last Ten Years (2009-2019) -Transient Receptor Potential Channels: Therapeutic Targets for Cardiometabolic Diseases? -Treatment of Raynaud’s Phenomenon -Traditional Medicine Based Cardiovascular Therapeutics -Cardiovascular Disease: A Systems Biology Approach
© 2020 Bentham Science (E-Book): 9789811413247
Erscheinungsdatum
E-Book: 3. Oktober 2020
Über 600.000 Titel
Lade Titel herunter mit dem Offline Modus
Exklusive Titel und Storytel Originals
Sicher für Kinder (Kindermodus)
Einfach jederzeit kündbar
Für alle, die unbegrenzt hören und lesen möchten.
1 Konto
Unbegrenzter Zugriff
Jederzeit kündbar
Wechsel zu Basic jederzeit möglich
Für alle, die gelegentlich hören und lesen.
1 Konto
20 Stunden/pro Monat
Jederzeit kündbar
Abo-Upgrade jederzeit möglich
Deutsch
Deutschland